J.P. Morgan Raises the PT on Ionis Pharmaceuticals (IONS), Keeps a Hold Rating
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is one of the Best Mid Cap Growth Stocks to Buy According to Hedge Funds. On…
Tag: Pharmaceuticals
U.S. and EU spell out tariffs for autos, pharmaceuticals, and more
U.S. President Donald Trump shakes hands with President of the European Commission Ursula von der Leyen as he announces a…
Vertex Pharmaceuticals (VRTX) Hits New All-Time Low on Failed Clinical Trial
We recently published 10 Big Names Bleed Double Digits. Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) is one of the worst-performing stocks on…
Trump Teases Tariffs on Chips, Pharmaceuticals
Sarah Bianchi, former deputy US trade representative said President Trump faces major challenges to his bid to use punishing tariffs to…
Arrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough Deal
We recently compiled a list of 11 Best Future Stocks to Buy Now. Arrowhead Pharmaceuticals, Inc. stands seventh on our…
Vertex Pharmaceuticals Incorporated (VRTX) Launches JOURNAVX, First Non-Opioid Acute Pain Treatment
We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Vertex Pharmaceuticals Incorporated stands…
Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best small cap AI stocks to buy according to analysts. On July…
Trump’s Latest Tariff Threat Puts Pharmaceuticals in Focus
Get caught up. www.bloomberg.com #Trumps #Latest #Tariff #Threat #Puts #Pharmaceuticals #Focus
Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) is among the fundamentally strong penny stocks to invest in. Analysts at H.C. Wainwright have reiterated…
Why Recursion Pharmaceuticals (RXRX) Soared On Friday
We recently published a list of 10 Stocks Are Dominating Like Wall Street Titans. In this article, we are going…